Drug Discovery

#AAV #Cryo-EM #cryo-microscopy #Drug discovery #Gene therapy #Webinar

Webinar: Adeno-associated virus vectors for gene therapy

In a webinar on 5 September, Professor Susumu Uchiyama, Department of Biotechnology, Graduate School of Engineering, Osaka University, will present his work around adeno-associated virus (AAV) characterisation using cryo-electron microscopy. The event is hosted by DDW and supported by Thermo Fisher Scientific. In… Read More

Webinar date:
Supported by Thermo Fisher Scientific
#News

Antibodies
#Antibodies #Antibody #Antibody discovery workflow #Drug discovery #Webinar

New webinar: Next-generation antibody discovery

Traditional hybridoma technology has long struggled with inefficiencies, especially in producing rabbit monoclonal antibodies. Join DDW on 9 September 3PM BST to find out how Fujifilm Wako has surmounted these challenges by integrating DNA immunisation with their proprietary single B-cell cloning technique, paving the way for… Read More

Webinar date:
Supported by Oxford Nanopore Technologies
#News

Mass spectrometry
#Drug discovery #Lab technology #Mass spectrometry / NMR #Tech Focus

Mass spectrometry: The cornerstone of modern drug discovery

DDW’s Diana Spencer examines the role of mass spectrometry in drug discovery and development. By measuring the mass-to-charge ratio of ions, mass spectrometry (MS) can identify unknown compounds, quantify known ones, and reveal the structure and chemical properties of molecules. It is highly sensitive and precise, making it an invaluable… Read More

#Exclusive Content

#Asthma #Cell sequencing #Drug discovery #Drug targets #Immunogenomics #Meet the Researcher

Meet the researcher: Timothy Hinks

DDW’s Megan Thomas talks to Professor Timothy Hinks, Associate Professor in Respiratory Immunology, Nuffield Department of Medicine. MT: Can you tell us what you do and what you’re working on at the moment? TH: I’m a clinician scientist, which I think is the best job in the world. Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Biotech #Drug development #Drug discovery

Rethinking the pharma R&D lifecycle with AI in mind

Ashu Singhal and Sajith Wickramasekara, co-founders of Benchling, explore how AI’s true promise for the pharmaceutical industry can only be realised if the entire pharmaceutical R&D lifecycle is supported. Drug discovery has quickly become a trendy place to apply AI. Read More

#Exclusive Content

Heart
#AstraZeneca #Clinical trials #Drug development #Drug discovery #Heart failure

Early diagnosis and intervention in heart failure

Heart failure is a collection of different diseases, which can be hard to define and treat through routine clinical practice. Heart failure affects 64 million people globally and approximately half of patients with heart failure die within five years of diagnosis. Real-world data presented at the European Society of Cardiology’s… Read More

#Exclusive Content

Drug discovery innovation
#AAV #Cell and gene therapy #Drug development #Drug discovery #Gene therapy #Genetics / genomics #Immunology / Virology & Vaccines #Interview #Life sciences #Market reporting #Precision medicine #RNA #RNA sequencing #Scandinavia #Sweden #Transcriptomics

Podcast: Innovation drivers and opportunities for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Innovation drivers and opportunities for drug discovery”, which covers three articles written Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Optimising AAV capsid purification through improved analytics How… Read More

#News

Image of the earth showing the UK and Scandinavia
#ABPI #Drug discovery #Investment #Life sciences #Medicines Discovery Catapult (MDC)

Why the UK needs to nurture a fit-to-fund life sciences sector 

Professor Chris Molloy, CEO of Medicines Discovery Catapult (MDC), writes about the state of the UK’s drug discovery sector, exploring economic challenges and what is needed to support the country’s rich life sciences talent.   We should all be proud of and inspired by the UK life… Read More

#Exclusive Content

Handshake jigsaw puzzle
#AI / data analytics / healthtech / informatics #Collaboration #Lab space #Lab technology #Partnership #Sapio Sciences #Zifo

Industry players partner to provide lab informatics  

Sapio Sciences and Zifo have announced a strategic partnership to bring best-in-class laboratory information management solutions to customers across the biotech, clinical diagnostics, and pharmaceutical industries.  Zifo will join the Sapio Sciences Partner Program as a services partner, focusing on delivering solutions that combine Zifo’s IT services… Read More

#News

#Drug discovery #High throughput screening #Multi-omics #Omics

Understanding the value of multi-omics

DDW’s Megan Thomas discusses the opportunity in the multi-omics sector by speaking with leading players and looking at the ways in which it can help us tackle disease. Importance of the multi-omics sector Multi-omics describes the crossover application of many high‐throughput screening technologies. These include genomics, transcriptomics, proteomics, metabolomics, epigenomics, glycomics,… Read More

#Exclusive Content

#Advanced Therapies #Cell and gene therapy #Cell therapy #Drug discovery #eBook #Gene therapy

New eBook: Creating opportunities from advanced therapies

Cell and gene therapies (CGTs) are the fastest growing area of therapeutics, with many preclinical and clinical programmes currently underway. While cancer is key target for CGTs, these advanced therapies are also under investigation to treat conditions as varied as asthma, multiple sclerosis, ophthalmological conditions like… Read More

#News

Hematopoietic stem cells in bone marrow.
#Drug discovery #Hematopoietic stem cells #In vitro #Non-animal model (NAM) #Stem cell transplant #University of Glasgow

New bone marrow model ‘big news’ for drug discovery

Scientists have created the first bioengineered bone marrow model which can support the type of human stem cells that are crucial for bone marrow transplants and in vitro study work. The research – published in Nature Communications and led by the University of… Read More

#Editor's Choice #News

Cancer cell
#AACR #Antibody drug conjugate (ADC) #Cancer research #Drug development #Drug discovery #Zymeworks

Finding protein therapeutics for cancer treatment  

The American Association of Cancer Research (AACR) Annual Meeting took place from 5-10 April 2024 in San Diego. DDW’s Megan Thomas spoke with Dr Paul Moore, Chief Scientific Officer at Zymeworks and Dr Nina Weisser, Director of Multispecific Antibody Therapeutics at Zymeworks, about the event as well as the… Read More

#Cancer Research #Exclusive Content

Events
#ASGCT #Blood donation #Drug delivery #Drug discovery #Events #ISCT #Pharma Sustainability Integrates #Synthetic & Engineering Biology British-Swiss Summit

Event highlights in 2024 so far  

There have been a number of key events in the drug discovery community’s diary in 2024 to date, from AACR 2024 and LSX Congress 2024 to SLAS 2024 in Boston and… Read More

#Exclusive Content

#Cancer research #Career #Chemical biology #Curve Therapeutics #Drug discovery #High throughput screening #Interview #Meet the Researcher #Next generation sequencing #Target identi

Meet the researcher: Ali Tavassoli

DDW’s Megan Thomas talks to Ali Tavassoli, Chief Scientific Officer of Curve Therapeutics and Professor of Chemical Biology at the University of Southampton, UK.  MT: Where do you work, and can you tell us what you’re working on at the moment?  AT: We spun Curve out of my academic… Read More

#Cancer Research #Exclusive Content